Appili Therapeutics Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 0/6

Appili Therapeutics has been growing earnings at an average annual rate of 0.5%, while the Pharmaceuticals industry saw earnings growing at 46% annually. Revenues have been growing at an average rate of 37.9% per year.

Anahtar bilgiler

0.5%

Kazanç büyüme oranı

18.2%

EPS büyüme oranı

Pharmaceuticals Sektör Büyümesi23.1%
Gelir büyüme oranı37.9%
Özkaynak getirisin/a
Net Marj-461.4%
Son Kazanç Güncellemesi30 Jun 2024

Yakın geçmiş performans güncellemeleri

Güncelleme yok

Recent updates

Market Sentiment Around Loss-Making Appili Therapeutics Inc. (TSE:APLI)

Mar 24
Market Sentiment Around Loss-Making Appili Therapeutics Inc. (TSE:APLI)

Appili Therapeutics Inc.'s (TSE:APLI) Shift From Loss To Profit

Dec 09
Appili Therapeutics Inc.'s (TSE:APLI) Shift From Loss To Profit

Gelir ve Gider Dağılımı

Appili Therapeutics nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.


Kazanç ve Gelir Geçmişi

TSX:APLI Gelir, gider ve kazançlar (CAD Millions )
TarihGelirKazançlarG+A GiderleriAr-Ge Giderleri
30 Jun 241-436
31 Mar 241-436
31 Dec 231-545
30 Sep 231-845
30 Jun 230-854
31 Mar 230-954
31 Dec 220-1053
30 Sep 221-1156
30 Jun 221-20516
31 Mar 221-25521
31 Dec 211-27624
30 Sep 210-28624
30 Jun 210-19615
31 Mar 210-14510
31 Dec 200-1156
30 Sep 200-854
30 Jun 200-643
31 Mar 200-542
31 Dec 190-542
30 Sep 190-543
30 Jun 190-643
31 Mar 190-433
31 Dec 180-434
31 Mar 180-424

Kaliteli Kazançlar: APLI is currently unprofitable.

Büyüyen Kar Marjı: APLI is currently unprofitable.


Serbest Nakit Akışı ve Kazanç Analizi


Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: APLI is unprofitable, but has reduced losses over the past 5 years at a rate of 0.5% per year.

Büyüme Hızlandırma: Unable to compare APLI's earnings growth over the past year to its 5-year average as it is currently unprofitable

Kazançlar vs. Sektör: APLI is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (-40.8%).


Özkaynak Getirisi

Yüksek ROE: APLI's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Varlık Getirisi


Kullanılan Sermaye Getirisi


Geçmişte güçlü performans gösteren şirketleri keşfedin